180 Life Sciences Corp (ATNF)
2.24
-0.04
(-1.75%)
USD |
NASDAQ |
Nov 22, 14:51
180 Life Sciences Enterprise Value: 7.569M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 7.569M |
| November 20, 2024 | 7.688M |
| November 19, 2024 | 7.707M |
| November 18, 2024 | 7.628M |
| November 15, 2024 | 8.004M |
| November 14, 2024 | 8.360M |
| November 13, 2024 | 8.775M |
| November 12, 2024 | 8.953M |
| November 11, 2024 | 9.605M |
| November 08, 2024 | 8.795M |
| November 07, 2024 | 8.854M |
| November 06, 2024 | 9.052M |
| November 05, 2024 | 9.329M |
| November 04, 2024 | 9.823M |
| November 01, 2024 | 10.46M |
| October 31, 2024 | 10.81M |
| October 30, 2024 | 7.097M |
| October 29, 2024 | 7.611M |
| October 28, 2024 | 7.405M |
| October 25, 2024 | 7.436M |
| October 24, 2024 | 7.046M |
| October 23, 2024 | 7.426M |
| October 22, 2024 | 7.878M |
| October 21, 2024 | 8.165M |
| October 18, 2024 | 8.227M |
| Date | Value |
|---|---|
| October 17, 2024 | 7.508M |
| October 16, 2024 | 9.706M |
| October 15, 2024 | 4.622M |
| October 14, 2024 | 4.458M |
| October 11, 2024 | 4.417M |
| October 10, 2024 | 4.407M |
| October 09, 2024 | 4.468M |
| October 08, 2024 | 4.273M |
| October 07, 2024 | 4.499M |
| October 04, 2024 | 4.520M |
| October 03, 2024 | 4.479M |
| October 02, 2024 | 4.509M |
| October 01, 2024 | 4.643M |
| September 30, 2024 | 4.776M |
| September 27, 2024 | 1.021M |
| September 26, 2024 | 1.093M |
| September 25, 2024 | 1.216M |
| September 24, 2024 | 1.216M |
| September 23, 2024 | 1.206M |
| September 20, 2024 | 1.319M |
| September 19, 2024 | 1.268M |
| September 18, 2024 | 1.381M |
| September 17, 2024 | 1.340M |
| September 16, 2024 | 1.175M |
| September 13, 2024 | 1.155M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.9052M
Minimum
Dec 12 2023
361.77M
Maximum
Apr 12 2021
64.20M
Average
25.86M
Median
Enterprise Value Benchmarks
| Seelos Therapeutics Inc | 10.03M |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
| Theriva Biologics Inc | -12.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.8367M |
| Total Expenses (Quarterly) | 0.9791M |
| EPS Diluted (Quarterly) | -0.85 |
| Earnings Yield | -214.9% |